Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03094806 · ClinicalTrials.gov registry record · NA
Vibratory PEP Device and Hospital Length of Stay for Acute Exacerbation of COPD
A NA study of Chronic Obstructive Pulmonary Disease, sponsored by New York Presbyterian Brooklyn Methodist Hospital.
- Completed
- Registry status
- NA
- Development phase
- 91
- Enrollment target
- 1
- Study location
NCT03094806: Completed NA study of Chronic Obstructive Pulmonary Disease, sponsored by New York Presbyterian Brooklyn Methodist Hospital.
NCT03094806 is a NA study of Chronic Obstructive Pulmonary Disease that has completed, run by New York Presbyterian Brooklyn Methodist Hospital. The registered enrollment target is 91 participants, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03094806, a NA study of Chronic Obstructive Pulmonary Disease, has completed, sponsored by New York Presbyterian Brooklyn Methodist Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is evaluating the use of a respiratory device, the Acapella Vibratory Positive Expiratory Pressure (PEP) Therapy device, in patients admitted to the hospital with a chronic obstructive pulmonary disease (COPD) exacerbation.
Primary Outcome
Time of admission to time of discharge from hospital
Conditions Studied
Interventions
- DEVICE Acapella Vibratory PEP Therapy Device plus usual care
- DEVICE Sham Acapella Vibratory PEP Device plus usual care
Study Locations (1)
New York
- New York Methodist Hospital - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT03094806 record still lists
NCT03094806 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 2 interventions - of which Acapella Vibratory PEP Therapy Device plus usual care is the first listed.
NCT03094806 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03094806 about?
NCT03094806 is a clinical study titled "Vibratory PEP Device and Hospital Length of Stay for Acute Exacerbation of COPD". This study is evaluating the use of a respiratory device, the Acapella Vibratory Positive Expiratory Pressure (PEP) Therapy device, in patients admitted to the hospital with a chronic obstructive pulmonary disease (COPD) exacerbation.
What is the current status of trial NCT03094806?
This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2013-10. Estimated completion is 2015-12.
What conditions does trial NCT03094806 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.
What interventions are being tested in trial NCT03094806?
The interventions under investigation include: Acapella Vibratory PEP Therapy Device plus usual care (DEVICE), Sham Acapella Vibratory PEP Device plus usual care (DEVICE).
Who is sponsoring clinical trial NCT03094806?
This trial is sponsored by New York Presbyterian Brooklyn Methodist Hospital, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03094806 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03094806's enrollment target sits among peer trials
91 54th of 86 higher than 33 of 86 other Chronic Obstructive Pulmonary Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Obstructive Pulmonary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
RECRUITING · NA
-
Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling
RECRUITING · NA
-
PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
RECRUITING · NA
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia